Crossmark

Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Definitively Does not Deserve Its Bad Reputation

Published Online: 2021-02-20

Published Print: 2021-09

Authors

Noiret, B.

Piessen, G.

Eveno, C.
License Information

Text and Data Mining valid from 2021-02-20

Version of Record valid from 2021-02-20
More Information

Article History

Received: 19 January 2021

Accepted: 26 January 2021

First Online: 20 February 2021

Disclosure

: The authors declare no conflict of interest.

Document is current